LMR Partners’s LAVA Medtech Acquisition Corp. Unit LVACU Stock Holding History

LMR Partners’s Portfolio LVACU Stock Details LVACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-25,000	Closed	-$251K	–	1630
2022 Q3	$251K	Hold	25,000	–	–	﹤0.01%	983
2022 Q2	$251K	Hold	25,000	–	–	﹤0.01%	1033
2022 Q1	$252K	Hold	25,000	–	–	﹤0.01%	1106
2021 Q4	$252K	Buy	+25,000	New	+$253K	﹤0.01%	1032

Other funds holding LVACU

CIM

Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LMR Partners's LVACU Position: Q4 2022 in Review

LMR Partners sold out of LAVA Medtech Acquisition Corp. Unit (LVACU) in Q4 2022, closing a stake of 25,000 shares — an estimated $251K sold.

LMR Partners first reported a position in LVACU in Q4 2021 and held it in 4 quarters. The position peaked at $252K in Q1 2022. 6 funds tracked by Wall St. Rank hold LVACU as of Q4 2022.

LMR Partners reported no remaining LAVA Medtech Acquisition Corp. Unit position as of Q4 2022 after selling out during the quarter.
LMR Partners sold 25,000 LAVA Medtech Acquisition Corp. Unit shares in Q4 2022, an estimated $251K.
LMR Partners first reported a position in LAVA Medtech Acquisition Corp. Unit in Q4 2021 and held it in 4 quarters.
LMR Partners's LAVA Medtech Acquisition Corp. Unit position peaked at $252K in Q1 2022.
6 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Unit as of Q4 2022.

Based on LMR Partners's 13F filing for Q4 2022, filed 14 Feb 2023.